摘要
单链内生的~22nt的微小RNA的最新报道展示了它们不同的生物功能,包括细胞分化、细胞周期和病理学条件。最近的研究显示了微小RNA在干细胞工程中的潜在应用。微小RNA作为基因表达的后转录调节器发挥着重要作用,控制着骨母细胞调控的骨形成和破骨细胞相关的骨重塑。转录和转录后机制调节骨母细胞的分化和骨生成。骨母细胞的分化为骨骼肌的发展的关键步骤,且参与触发信号通路。信号通路如TGFβ、 BMP 和 Wnt是由微小RNA反调控的,因而与骨动力学和骨骼疾病有关。这篇综述突出微小RNA在骨母细胞分化的作用,并强调它们在骨代谢紊乱中的潜在治疗作用。
关键词: 骨紊乱,微小RNA,骨细胞分化,信号通路
Current Medicinal Chemistry
Title:Role of microRNAs in Osteoblasts Differentiation and Bone Disorders
Volume: 22 Issue: 6
Author(s): Yasir Arfat, Wei-Zhong Xiao, Munazza Ahmad, Fan Zhao, Di-Jie Li, Yu-Long Sun, Lifang Hu, Chen Zhihao, Ge Zhang, Salman Iftikhar, Peng Shang, Tuan-Ming Yang and Ai-Rong Qian
Affiliation:
关键词: 骨紊乱,微小RNA,骨细胞分化,信号通路
摘要: Advanced studies of single stranded endogenous ~22 nt microRNAs (miRNAs) have demonstrated their diverse biological functions including control of cell differentiation, cell cycle and pathological conditions. Recent studies suggest the potential application of miRNAs in stem cell engineering. miRNAs play a vital role as post-transcriptional regulators of gene expression which controls osteoblasts-mediated bone formation and osteoclasts related bone remodeling. Transcriptional and post-transcriptional mechanisms regulate the differentiation of osteoblasts and osteogenesis. The differentiation of osteoblasts is a key step in the development of skeletal muscles and it is involved in triggering the signaling pathways. Signaling pathways like TGFβ, BMP and Wnt are regulated by miRNAs which in turn, are shown to be associated with bone dynamics and bone disorders. This recap highlights the role of miRNAs in osteoblasts differentiation and emphasizes their potential therapeutic role in metabolic bone disorders.
Export Options
About this article
Cite this article as:
Yasir Arfat , Wei-Zhong Xiao , Munazza Ahmad , Fan Zhao , Di-Jie Li , Yu-Long Sun , Lifang Hu , Chen Zhihao , Ge Zhang , Salman Iftikhar , Peng Shang , Tuan-Ming Yang and Ai-Rong Qian , Role of microRNAs in Osteoblasts Differentiation and Bone Disorders, Current Medicinal Chemistry 2015; 22 (6) . https://dx.doi.org/10.2174/0929867321999141106121227
DOI https://dx.doi.org/10.2174/0929867321999141106121227 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Anti-Cancer Agents in Medicinal Chemistry Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
Current Cancer Drug Targets Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
Current Drug Metabolism Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Systematic Analysis of RNAi Reports Identifies Dismal Commonality at Gene-Level and Reveals an Unprecedented Enrichment in Pooled shRNA Screens
Combinatorial Chemistry & High Throughput Screening New Insights on the Xenobiotic-Sensing Nuclear Receptors in Liver Diseases – CAR and PXR-
Current Drug Metabolism Identifying Molecular Biomarker for the Lung Squamous Cell Carcinoma by Integrating Multifactorial Data
Current Bioinformatics Peptide Nucleic Acids with a Structurally Biased Backbone: Effects of Conformational Constraints and Stereochemistry
Current Topics in Medicinal Chemistry Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review
Current Medicinal Chemistry Interactions Between Proteins and Platinum-Containing Anti-Cancer Drugs
Mini-Reviews in Medicinal Chemistry Potential Usage of ING Family Members in Cancer Diagnostics and Molecular Therapy
Current Drug Targets Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Paclitaxel Loaded Nanoliposomes in Thermosensitive Hydrogel: A Dual Approach for Sustained and Localized Delivery
Anti-Cancer Agents in Medicinal Chemistry Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.
Current Pharmaceutical Design MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment
Recent Patents on Anti-Cancer Drug Discovery Clinical Pharmacology of Cyclophosphamide and Ifosfamide
Current Drug Therapy Toxic Epidermal Necrolysis and Antifolate Drugs in Cancer Chemotherapy
Current Drug Safety Modulation of Cellular Function by TAT Mediated Transduction of Full Length Proteins
Current Protein & Peptide Science A Closer Look at Protein Transduction Domains as a Tool in Drug Delivery
Current Nanoscience Anticancer Antifolates: Current Status and Future Directions
Current Pharmaceutical Design